title: Measuring airway surface liquid depth in ex vivo mouse airways by x-ray imaging for the assessment of cystic fibrosis airway therapies.
abstract: In the airways of those with cystic fibrosis (CF), the leading pathophysiological hypothesis is that an ion channel defect results in a relative decrease in airway surface liquid (ASL) volume, producing thick and sticky mucus that facilitates the establishment and progression of early fatal lung disease. This hypothesis predicts that any successful CF airway treatment for this fundamental channel defect should increase the ASL volume, but up until now there has been no method of measuring this volume that would be compatible with in vivo monitoring. In order to accurately monitor the volume of the ASL, we have developed a new x-ray phase contrast imaging method that utilizes a highly attenuating reference grid. In this study we used this imaging method to examine the effect of a current clinical CF treatment, aerosolized hypertonic saline, on ASL depth in ex vivo normal mouse tracheas, as the first step towards non-invasive in vivo ASL imaging. The ex vivo tracheas were treated with hypertonic saline, isotonic saline or no treatment using a nebuliser integrated within a small animal ventilator circuit. Those tracheas exposed to hypertonic saline showed a transient increase in the ASL depth, which continued for nine minutes post-treatment, before returning to baseline by twelve minutes. These findings are consistent with existing measurements on epithelial cell cultures, and therefore suggest promise for the future development of in vivo testing of treatments. Our grid-based imaging technique measures the ASL depth with micron resolution, and can directly observe the effect of treatments expected to increase ASL depth, prior to any changes in overall lung health. The ability to non-invasively observe micron changes in the airway surface, particularly if achieved in an in vivo setting, may have potential in pre-clinical research designed to bring new treatments for CF and other airway diseases to clinical trials.
authors: School of Physics, Monash University, Melbourne, Victoria, Australia. kaye.morgan@monash.edu
authors: Kaye S
authors: KS
authors: Morgan
authors: Martin
authors: M
authors: Donnelley
authors: David M
authors: DM
authors: Paganin
authors: Andreas
authors: A
authors: Fouras
authors: Naoto
authors: N
authors: Yagi
authors: Yoshio
authors: Y
authors: Suzuki
authors: Akihisa
authors: A
authors: Takeuchi
authors: Kentaro
authors: K
authors: Uesugi
authors: Richard C
authors: RC
authors: Boucher
authors: David W
authors: DW
authors: Parsons
authors: Karen K W
authors: KK
authors: Siu
mesh_terms: D000818:Animals; D003550:Cystic Fibrosis / Q000000981:diagnostic imaging* / Q000628:therapy; D045604:Extracellular Fluid; D005260:Female; D066298:In Vitro Techniques; D051379:Mice; D011859:Radiography; D020545:Respiratory Mucosa / Q000378:metabolism*; D013997:Time Factors; D014132:Trachea / Q000378:metabolism
references: Phys Med Biol. 2008 Nov 7;53(21):6065-77
references: 18843172
references: Am J Physiol Lung Cell Mol Physiol. 2009 Dec;297(6):L1131-40
references: 19820035
references: Opt Lett. 2004 Apr 15;29(8):866-8
references: 15119404
references: J Synchrotron Radiat. 2010 Nov;17(6):719-29
references: 20975216
references: Opt Express. 2011 Sep 26;19(20):19781-9
references: 21996920
references: Opt Lett. 2011 Jan 1;36(1):55-7
references: 21209685
references: Mol Cell. 2001 Jul;8(1):149-58
references: 11511368
references: Eur Respir J. 2004 Jan;23(1):146-58
references: 14738247
references: Cell. 1998 Dec 23;95(7):1005-15
references: 9875854
references: J Clin Invest. 2002 Mar;109(5):571-7
references: 11877463
references: Eur Respir J. 1996 Apr;9(4):725-32
references: 8726937
references: N Engl J Med. 2006 Jan 19;354(3):241-50
references: 16421365
references: Am J Respir Crit Care Med. 2005 Nov 15;172(10):1246-52
references: 16100011
references: J Biol Chem. 2005 Oct 21;280(42):35751-9
references: 16087672
references: J Cyst Fibros. 2005 May;4(2):89-100
references: 15914096
references: Curr Pharm Des. 2012;18(5):614-27
references: 22229570
references: N Engl J Med. 2011 Nov 3;365(18):1663-72
references: 22047557
references: N Engl J Med. 2006 Jan 19;354(3):229-40
references: 16421364
references: J Intern Med. 2007 Jan;261(1):5-16
references: 17222164